Product Information
AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE is a brand product labeled by Mannkind Corporation, priced at $15.6530 per EA under NDC 47918089190. Its NADAC has been published 93 times since Apr 17, 2024.
Strength
12 [arb'U]/1
Manufacturer
Mannkind CorporationNDC
47918089190
Classification
Brand
Dosage Form
POWDER, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
5/20/2026
Active Ingredients
INSULIN HUMANApproval Type
Biologic (BLA)
FDA Application
BLA022472On Market Since
7/1/2017
Pharmacological Classes
Price Statistics
The NADAC for AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE has been published 93 times since Apr 17, 2024, and over the history we have for it it has risen 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.6530 per EA |
|---|---|
| All-time high | $15.6530 (Jun 24, 2026) |
| All-time low | $14.3802 (Apr 17, 2024) |
| 52-week high | $15.6530 |
| 52-week low | $15.1848 |
| Median price | $15.1848 |
| Average price | $14.9322 |
| Largest weekly change | +5.0% (Dec 18, 2024) |
| Weeks tracked | 93 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the INSULIN HUMAN market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE?
The current National Average Drug Acquisition Cost (NADAC) for AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE, manufactured by Mannkind Corporation, is $15.6530 per EA (NDC 47918089190), effective Jun 24, 2026.
How has the price of AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE changed over time?
Over the history we have for it, the NADAC for AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE has risen 8.9%. It has been tracked across 93 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE?
Since Apr 17, 2024, the NADAC for AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE has ranged from a low of $14.3802 (Apr 17, 2024) to a high of $15.6530 (Jun 24, 2026), with a median of $15.1848 per EA.
Are there cheaper alternatives to AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE, so no direct lower-cost alternative is listed.
Who manufactures AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE?
AFREZZA (REGULAR INSULIN) 12 UNIT CARTRIDGE (NDC 47918089190) is labeled by Mannkind Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification